Unknown

Dataset Information

0

Nonerythropoietic Erythropoietin-Derived Peptide Suppresses Adipogenesis, Inflammation, Obesity and Insulin Resistance.


ABSTRACT: Erythropoietin (EPO) has been identified as being crucial for obesity modulation; however, its erythropoietic activity may limit its clinical application. EPO-derived Helix B-surface peptide (pHBSP) is nonerythrogenic but has been reported to retain other functions of EPO. The current study aimed to evaluate the effects and potential mechanisms of pHBSP in obesity modulation. We found that pHBSP suppressed adipogenesis, adipokine expression and peroxisome proliferator-activated receptor ? (PPAR?) levels during 3T3-L1 preadipocyte maturation through the EPO receptor (EPOR). In addition, also through EPOR, pHBSP attenuated macrophage inflammatory activation and promoted PPAR? expression. Furthermore, PPAR? deficiency partly ablated the anti-inflammatory activity of pHBSP in macrophages. Correspondingly, pHBSP administration to high-fat diet (HFD)-fed mice significantly improved obesity, insulin resistance (IR) and adipose tissue inflammation without stimulating hematopoiesis. Therefore, pHBSP can significantly protect against obesity and IR partly by inhibiting adipogenesis and inflammation. These findings have therapeutic implications for metabolic disorders, such as obesity and diabetes.

SUBMITTER: Liu Y 

PROVIDER: S-EPMC4602313 | biostudies-literature | 2015 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Nonerythropoietic Erythropoietin-Derived Peptide Suppresses Adipogenesis, Inflammation, Obesity and Insulin Resistance.

Liu Yuqi Y   Luo Bangwei B   Shi Rongchen R   Wang Jinsong J   Liu Zongwei Z   Liu Wei W   Wang Shufeng S   Zhang Zhiren Z  

Scientific reports 20151013


Erythropoietin (EPO) has been identified as being crucial for obesity modulation; however, its erythropoietic activity may limit its clinical application. EPO-derived Helix B-surface peptide (pHBSP) is nonerythrogenic but has been reported to retain other functions of EPO. The current study aimed to evaluate the effects and potential mechanisms of pHBSP in obesity modulation. We found that pHBSP suppressed adipogenesis, adipokine expression and peroxisome proliferator-activated receptor γ (PPARγ  ...[more]

Similar Datasets

| S-EPMC3745597 | biostudies-literature
| S-EPMC2504825 | biostudies-literature
2023-11-06 | PXD045836 | Pride
| S-EPMC7210565 | biostudies-literature
| S-EPMC2922582 | biostudies-other
| S-EPMC7250139 | biostudies-literature
2015-05-18 | E-GEOD-58952 | biostudies-arrayexpress
| S-EPMC4023466 | biostudies-literature
| S-EPMC4350682 | biostudies-literature
| S-EPMC5085277 | biostudies-literature